Biotech

Quick-Med Technologies Appoints Bernd Liesenfeld as President

GAINESVILLE, FL: Roy Carr Promoted to Vice President of Business Development and William Toreki to Vice President of Research & Development as Part of Management Transition ...

La Jolla Pharmaceutical Company Announces FDA Agreement With Proposed Phase 1 Clinical Trial of GCS-100 in Chronic Kidney Disease

SAN DIEGO, CA: ...

Sarepta Therapeutics to Present Company Overview at the Wedbush PacGrow Life Sciences Management Access Conference

CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...

Peregrine Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

TUSTIN, CA: ...

Aeolus Pharmaceuticals Announces AEOL 10150 Diminishes Oxidative Stress and Nerve Damage Following Exposure to Nerve Agent

MISSION VIEJO, CA: ...

Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results on August 10, 2012

DEERFIELD, IL: ...

ProMetic Life Sciences and NantPharma, a NantWorks Company, to Develop and Commercialize Plasma-Derived Biopharmaceuticals

LOS ANGELES, USA and LAVAL, QUEBEC, CANADA: - ProMetic receives an initial US $2.5 Million from NantPharma - ProMetic to be exclusive development partner - ProMetic to manufacture bulk active at its Laval facility - ProMetic to retain rights to ...

Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: ...

Sarepta Therapeutics Regains NASDAQ Compliance

CAMBRIDGE, MA: ...

Harper Government Teams With Canadian Researchers to Bolster Food Safety System

OTTAWA, ONTARIO: ...